www.dilab.se

Press releases

 

2010-02-05
CMA acquires industry leader DiLab 

2008-09-16
CMA raises SEK 70 million in growth capital  

2007-11-04
CMA Launches new CE-approved catheter for dermatology use  

2007-10-01
CMA launches system for continuous bedside glucose monitoring.

2006-09-12
CMA Microdialysis AB launches new catheter for use in microvascular free flap surgery

2006-05-04
ISCUS Clinical Microdialysis Analyzer receives FDA 510(k) clearance

2005-12-29
CMA Microdialysis and Pronexus form strategic partnership to offer Microdialysis contract research services

2005-12-19
CMA Microdialysis AB announces the release of its new Linear Microdialysis Probe for research 

2005-08-16
CMA Microdialysis raises 38 MSEK in new funding 

2005-04-14
Philip Siberg has been appointed as CEO of CMA Microdialysis, a subsidiary of Skanditek.

2004-12-30
CMA Microdialysis has as one of the first biotechnology companies in Scandinavia obtained certificate
for the ISO13485:2003 quality standard.

2004-11-15
CMA Microdialysis AB announces the release of its new High Cut-Off Membrane Catheter

2002-10-29
CMA Microdialysis receives FDA 510(k) clearance for Cerebral Tissue Monitoring System for adjunct use in monitoring brain trauma patients at risk for ischemia.

--------------------------------------------------------------------------------------------------------------------------------

About CMA Microdialysis AB

CMA Microdialysis is the leading company devoted to the development, manufacturing and marketing of Microdialysis based solutions. 
The company was formed in 1984 and was the first company in the world to market Microdialysis products and know-how.
CMA’s solutions are used in intensive care and research as unique tools for in vivo monitoring and diagnostics. CMA has offices in Sweden and USA and distributors in more than 40 countries. 
For more information see www.microdialysis.com

Philip Siberg, CEO
Tel +46 70 790 6743
E-mail: philip.siberg@microdialysis.se